CLYM
Ticker
Climb Bio, Inc.
CLYM · Healthcare · Climb Bio, Inc., a clinical-stage biotechnology company, focuses on developing therapies to address unmet needs for patients living with im…Climb Bio, Inc. (CLYM), in the Healthcare sector, has 5 disclosed filings on Paydirt over the trailing twelve months from 3 corporate insiders: 1 purchase and 4 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Sep 15 and filed Sep 17. The most active filer was Stephen Basil Thomas with 3 filings.
Add to watchlistFilings, ttm
5
1 buy · 4 sells
Traders, ttm
3
3 insiders
Volume, ttmiDollar value disclosed in the window
$3.3M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Sep 15
Filed Sep 17
ADViAverage daily dollar volume
$22.3M
market data
Share price · 12M
$14.05 (+505.6%)
Adjusted for splits and dividends.
Volume by month
Buys $755K
Sells $2.6M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
STRecent filings
Stephen Basil ThomasSALE
Director
$1.4M100,000 sh × $13.67
Exec Sep 15
Filed Sep 17 · 4:15 PM ET Aoife BrennanSALE President and CEO $407K
30,902 sh × $13.17
Exec Jun 29
Filed Jun 30 · 5:30 PM ET Stephen Basil ThomasSALE Director $350K
50,000 sh across 2 lots
Exec Feb 25
Filed Feb 27 · 5:30 PM ET Stephen Basil ThomasSALE Director $471K
90,000 sh × $5.23
Exec Feb 12
Filed Feb 17 · 5:30 PM ET Ra Capital Management, L.P.PURCHASE Director $755K
314,561 sh across 2 lots
Exec Dec 11 2025
Filed Dec 15 2025 · 7:55 PM ET